News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
DNA Differences May Explain Why Some Melanoma Patients Don’t Respond to Immunotherapy – CRI
nyulangone.org
Jun 16, 2025, 07:06

DNA Differences May Explain Why Some Melanoma Patients Don’t Respond to Immunotherapy – CRI

Cancer Research Institute (CRI) shared a post on LinkedIn:

“In a new study, researchers, including CRI Scientific Advisory Council member Dr. Thomas Gajewski of the University of Chicago, observed that patients with metastatic melanoma who did not respond to immune checkpoint inhibitors had DNA with differences not found in the DNA of those who did respond. NYU Langone Health describes how these findings ‘help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do not respond to the latest cancer treatments.’ Discover.”

Read further.

More posts featuring CRI.

cancer Cancer Research Institute CRI metastatic melanoma OncoDaily Oncology Thomas Gajewski University of Chicago
Special Coverage
Positive
Aug 16, 2025, 17:07
A Milestone in Childhood Cancer Care: Wellness Center Inaugurated in San Lorenzo - Foundation S
Voices
Aug 16, 2025, 16:56
Strengthening National Cancer Control Plans for Equitable Care - UICC
Voices
Aug 16, 2025, 16:41
Meet the Researchers: Lekha Mikkilineni - Conquer Cancer, the ASCO Foundation
Positive
Aug 16, 2025, 16:28
Ebony Boulware: Honored to Join the Investiture of Joshua Patt as Inaugural Endowed Chair for Sarcoma Research
Drugs
Aug 16, 2025, 16:14
Cemiplimab-rwlc (Libtayo) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and more
Voices
Aug 16, 2025, 15:59
Sigrun Hallmeyer: Honored to be Recognized With CWC Impact Award
Voices
Aug 16, 2025, 15:58
Comprehensive Agenda for AdventHealth Cancer Institute's 12th Annual Officially Licensed Best of ASCO
Voices
Aug 16, 2025, 15:56
Winette van der Graaf: Long-term Survival of AYA Solid Cancer Survivors Supports Changes to Right To Be Forgotten Laws
Insight
Aug 16, 2025, 15:55
John H. Stewart IV: First Completed Randomized Trial with Oncologic Endpoints for Appendiceal Cancer
Insight
Aug 16, 2025, 15:53
NIH Researchers Explore ERVs as Promising Cancer Targets
Voices
Aug 16, 2025, 15:50
Chuck Stravin: From Patient to Advocate - Why the Jimmy Fund Telethon Matters
Voices
Aug 16, 2025, 15:49
Registration Is Open for the 2025 ESGO-ENYGO Masterclass in Tbilisi